Clinical trials
Intestinal Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Royal Marsden NHS Foundation Trust | 3 |
| Pharmbio Korea Co., Ltd. | 2 |
| University of Aarhus | 2 |
| Assiut University | 1 |
| Azienda Ospedaliera "Sant'Andrea" | 1 |
| Beijing Bozhiyin T&S Co., Ltd. | 1 |
| Belfast Health and Social Care Trust | 1 |
| Chinese PLA General Hospital | 1 |
| Fooyin University | 1 |
| Foundation for the National Institutes of Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intestinal Diseases | 45 |
| Digestive System Diseases | 11 |
| Gastrointestinal Diseases | 11 |
| Colorectal Neoplasms | 8 |
| Intestinal Neoplasms | 7 |
| Neoplasms | 7 |
| Rectal Neoplasms | 7 |
| Gastrointestinal Neoplasms | 6 |
| Colonic Diseases | 5 |
| Digestive System Neoplasms | 5 |
Trials
Showing 51 to 45 of 45. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.